The new director of the Centers for Disease Control and Prevention resigned positions at four entities, sold stock and forfeited options in two companies and is signing his share of future patent licensing fees and royalty payments over to his university to comply with government ethics rules, according to his financial disclosures.
Trending:
New CDC chief resigned from four entities to comply with ethics rules